Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRO 2000/5 Gel for the prevention of vaginally acquired HIV infection
NCT00262106Phase 3Completed
- Sponsor
- Endo International plc
- Start
- Oct 2005
- Primary completion
- Aug 2008
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of PRO 2000 in human immunodeficiency virus infection (HIV), genital herpes, gonorrhea, chlamydial infection, sponsored by Endo International plc. Started Oct 2005; status: completed.
02
Drugs
PRO 2000
03
Conditions
human immunodeficiency virus infection (HIV)genital herpesgonorrheachlamydial infection
Beyond the preview
Go deeper on NCT00262106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00262106.